Guidelines

Management of generalised anxiety disorder in adults: summary of NICE guidance

BMJ 2011; 342 doi: http://dx.doi.org/10.1136/bmj.c7460 (Published 26 January 2011)
Cite this as: BMJ 2011;342:c7460

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Tim Kendall, director1, visiting professor2, consultant psychiatrist and medical director3,
  2. John Cape, head4, visiting professor2,
  3. Melissa Chan, systematic reviewer1,
  4. Clare Taylor, editor1
  5. On behalf of the Guideline Development Group
  1. 1National Collaborating Centre for Mental Health, Royal College of Psychiatrists, London E1 8AA, UK
  2. 2University College London (Clinical, Educational and Health Psychology), London WC1E 7HB
  3. 3Sheffield Health and Social Care NHS Foundation Trust, Sheffield S10 3TH, UK
  4. 4Psychological Therapies, Camden and Islington NHS Foundation Trust, St Pancras Hospital, London NW1 0PE
  1. Correspondence to: Tim Kendall tim.kendall{at}shsc.nhs.uk

Generalised anxiety disorder affects about 4.4% of the adult population in England.1 It is characterised by worry and apprehension. Worries are typically widespread, involving everyday issues and a shifting focus of concern; a person with this disorder finds it difficult to control their worries.2 3 Like other anxiety disorders, it is often chronic if untreated,2 and it is associated with substantial disability equivalent to other chronic physical health problems such as arthritis and diabetes.4 People with generalised anxiety disorder have high levels of service use (visits to general practitioners and hospital), a consequence of somatic symptoms and worries commonly associated with the disorder and because it commonly coexists with chronic physical health problems.5 6 7

This article summarises the most recent recommendations from the partially updated guideline from the National Institute for Health and Clinical Excellence (NICE) on generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults.8 Only recommendations for the management of generalised anxiety disorder have been updated, and these are described here.

Recommendations

NICE recommendations are based on systematic reviews of best available evidence and explicit consideration of cost effectiveness. When minimal evidence is available, recommendations are based on the Guideline Development Group’s experience and opinion of what constitutes good practice. Evidence levels for the recommendations are given in italic in square brackets.

A “stepped care” model is used to organise and integrate the provision of care by general practices and community services and to help in choosing the most effective interventions. With this approach, patients are first offered the least intrusive intervention that might be effective, with a “step up” to more intensive interventions if they do not improve.

Identification, assessment, and initial treatment

  • Consider a diagnosis of generalised anxiety disorder in people presenting with anxiety or substantial worry and in people who attend …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL